
|Articles|January 28, 2015
- Head and Neck Cancers (Issue 3)
- Volume 3
- Issue 1
The Challenges of Treating Follicular Cell-Derived Thyroid Carcinoma
Author(s)Keith C. Bible, MD, PhD
Keith C. Bible, MD, PhD, professor of oncology, Mayo Clinic, discusses the challenges associated with treating patients with follicular cell-derived thyroid carcinoma.
Advertisement
Keith C. Bible, MD, PhD, professor of oncology, Mayo Clinic, discusses the challenges associated with treating patients with follicular cell-derived thyroid carcinoma.
<<<
Articles in this issue
about 11 years ago
Perspectives From the Clinic on AE Management in Thyroid Cancerabout 11 years ago
Urging Families With Thyroid Cancer to Seek Genetic Testingabout 11 years ago
Prognosis in Thyroid Cancer as Diverse as the Diseaseabout 11 years ago
The Diagnosis of Thyroid Cancerabout 11 years ago
National Surge in Thyroid Cancer Under Scrutinyabout 11 years ago
Epidemic in Sex-Related Oral Cancer Highlights Need for Guidelinesabout 11 years ago
Body Composition and Targeted Therapies in Thyroid CancerAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Accepts BLA for Ivonescimab in Pretreated EGFR-Mutated NSCLC
2
The Targeted Pulse: New Standards in Myeloma, Melanoma, and More
3
Onvansertib Triplet Shows Dose-Dependent Frontline Benefit in RAS-Mutant Metastatic CRC
4
Pembrolizumab/Lenvatinib Show Efficacy, Safety in Clear Cell Gyn Cancers
5


















